Zomedica Corp. (ZOMDF)
OTCMKTS · Delayed Price · Currency is USD
0.0500
+0.0140 (38.89%)
Mar 14, 2025, 4:00 PM EST

Zomedica Statistics

Total Valuation

Zomedica has a market cap or net worth of 49.05 million. The enterprise value is -20.49 million.

Market Cap 49.05M
Enterprise Value -20.49M

Important Dates

The last earnings date was Thursday, March 13, 2025.

Earnings Date Mar 13, 2025
Ex-Dividend Date n/a

Share Statistics

Zomedica has 979.95 million shares outstanding.

Current Share Class n/a
Shares Outstanding 979.95M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 0.73%
Owned by Institutions (%) 9.34%
Float 961.66M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.80
PB Ratio 0.25
P/TBV Ratio 0.50
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 0.44
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 0.71

Financial Position

The company has a current ratio of 8.76, with a Debt / Equity ratio of 0.01.

Current Ratio 8.76
Quick Ratio 7.98
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF -0.06
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -21.57% and return on invested capital (ROIC) is -9.95%.

Return on Equity (ROE) -21.57%
Return on Assets (ROA) -9.51%
Return on Invested Capital (ROIC) -9.95%
Return on Capital Employed (ROCE) -17.69%
Revenue Per Employee 189,479
Profits Per Employee -326,264
Employee Count 144
Asset Turnover 0.12
Inventory Turnover 1.61

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -64.03% in the last 52 weeks. The beta is 1.16, so Zomedica's price volatility has been higher than the market average.

Beta (5Y) 1.16
52-Week Price Change -64.03%
50-Day Moving Average 0.11
200-Day Moving Average 0.13
Relative Strength Index (RSI) 30.24
Average Volume (20 Days) 13,814,343

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Zomedica had revenue of 27.29 million and -46.98 million in losses. Loss per share was -0.05.

Revenue 27.29M
Gross Profit 19.09M
Operating Income -35.03M
Pretax Income -47.54M
Net Income -46.98M
EBITDA -27.04M
EBIT -35.03M
Loss Per Share -0.05
Full Income Statement

Balance Sheet

The company has 71.35 million in cash and 1.81 million in debt, giving a net cash position of 69.54 million or 0.07 per share.

Cash & Cash Equivalents 71.35M
Total Debt 1.81M
Net Cash 69.54M
Net Cash Per Share 0.07
Equity (Book Value) 195.66M
Book Value Per Share 0.20
Working Capital 72.44M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -23.63 million and capital expenditures -5.21 million, giving a free cash flow of -28.84 million.

Operating Cash Flow -23.63M
Capital Expenditures -5.21M
Free Cash Flow -28.84M
FCF Per Share -0.03
Full Cash Flow Statement

Margins

Gross margin is 69.95%, with operating and profit margins of -128.38% and -172.19%.

Gross Margin 69.95%
Operating Margin -128.38%
Pretax Margin -174.23%
Profit Margin -172.19%
EBITDA Margin -99.11%
EBIT Margin -128.38%
FCF Margin n/a

Dividends & Yields

Zomedica does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -95.79%
FCF Yield -58.81%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a